|Videos|March 27, 2023

Tweetorials: An Open Forum for Medical Education

An intensive care physician offers some insights looking at fluoroquinolone-associated tendinopathy and using this social media platform to provide education and an open discussion around it.


For the uninitiated, a tweetorial is using Twitter to provide education and information for mass consumption of any followers to the person providing the tweetorial. Essentially, it is the ability of someone to offer their expertise on certain topics that might be of interest to a greater audience.

Even in spite of the misinformation that permeates the social media platform today, Twitter can still be a place for medical education as well as the individual Twitter communities to come together to help each other in finding information and camaraderie.

Avraham Z. Cooper, MD, is a pulmonologist and intensive care physician at The Ohio State University Wexner Medical Center and he recently did a tweetorial looking at fluoroquinolone-associated tendinopathy. Although this class of antibiotics had a black box put on it many years ago to prevent tendon rupture, and there have been other issues associated with this class of antibiotics, it is still the only FDA approved oral pill option to treat pseudomonas, Cooper points out. Yet, there’s been a move away from using these medications as a first-line therapy because of the potential side effects.

In his tweetorial, Cooper mainly focused on understanding the mechanisms associated with fluoroquinolone-associated tendinopathy, but also touched upon the increased risk of aortic aneurysm and dissection.

Cooper sees this as an opportunity to not only educate others but also learn himself. “It was a known, unknown,” Cooper said of his tweetorial’s topic. “The FDA has this black box warning and I counsel patients on it, but I didn’t actual understand the mechanisms as to how an antibiotic could injury a tendon.” What he found most interesting was not only the number of patients who had been affected by this, but also the “wide swath” of different medical specialties who participated in the tweetorial.

Listed below in the slideshow are some screenshots of his tweetorial. And here is the link to the tweetorial thread.



Contagion spoke to Cooper about counseling patients who are prescribed fluoroquinolones, insights into his tweetorial, and the significance of using this forum for education.

For those who might be interested in creating a tweetorial but don’t know where to begin, check out this article from the American College of Cardiology on how to do so.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.